IL6 and steatosis: In particular, a 2-month intervention study enrolling 23 subjects with steatosis daily supplemented with EVOO with high oleocanthal concentration observed a reduction in body weight, waist circumference, alanine transaminase, and hepatic steatosis associated with a decrease in some inflammatory cytokines, IL6, IL17, TNF-α, and IL1β [85].